APAF1 Antibody - #AF4633
製品: | APAF1 Antibody |
カタログ: | AF4633 |
タンパク質の説明: | Rabbit polyclonal antibody to APAF1 |
アプリケーション: | WB |
反応性: | Human, Mouse, Rat |
予測: | Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Chicken, Xenopus |
分子量: | 139kDa; 142kD(Calculated). |
ユニプロット: | O14727 |
RRID: | AB_2844656 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF4633, RRID:AB_2844656.
折りたたみ/展開
APAF 1; Apaf-1; APAF_HUMAN; Apaf1; Apoptotic peptidase activating factor 1; Apoptotic protease activating factor 1; Apoptotic protease activating factor; Apoptotic protease-activating factor 1; CED 4; CED4; KIAA0413;
免疫原
Ubiquitous. Highest levels of expression in adult spleen and peripheral blood leukocytes, and in fetal brain, kidney and lung. Isoform 1 is expressed in heart, kidney and liver.
- O14727 APAF_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDAKARNCLLQHREALEKDIKTSYIMDHMISDGFLTISEEEKVRNEPTQQQRAAMLIKMILKKDNDSYVSFYNALLHEGYKDLAALLHDGIPVVSSSSGKDSVSGITSYVRTVLCEGGVPQRPVVFVTRKKLVNAIQQKLSKLKGEPGWVTIHGMAGCGKSVLAAEAVRDHSLLEGCFPGGVHWVSVGKQDKSGLLMKLQNLCTRLDQDESFSQRLPLNIEEAKDRLRILMLRKHPRSLLILDDVWDSWVLKAFDSQCQILLTTRDKSVTDSVMGPKYVVPVESSLGKEKGLEILSLFVNMKKADLPEQAHSIIKECKGSPLVVSLIGALLRDFPNRWEYYLKQLQNKQFKRIRKSSSYDYEALDEAMSISVEMLREDIKDYYTDLSILQKDVKVPTKVLCILWDMETEEVEDILQEFVNKSLLFCDRNGKSFRYYLHDLQVDFLTEKNCSQLQDLHKKIITQFQRYHQPHTLSPDQEDCMYWYNFLAYHMASAKMHKELCALMFSLDWIKAKTELVGPAHLIHEFVEYRHILDEKDCAVSENFQEFLSLNGHLLGRQPFPNIVQLGLCEPETSEVYQQAKLQAKQEVDNGMLYLEWINKKNITNLSRLVVRPHTDAVYHACFSEDGQRIASCGADKTLQVFKAETGEKLLEIKAHEDEVLCCAFSTDDRFIATCSVDKKVKIWNSMTGELVHTYDEHSEQVNCCHFTNSSHHLLLATGSSDCFLKLWDLNQKECRNTMFGHTNSVNHCRFSPDDKLLASCSADGTLKLWDATSANERKSINVKQFFLNLEDPQEDMEVIVKCCSWSADGARIMVAAKNKIFLFDIHTSGLLGEIHTGHHSTIQYCDFSPQNHLAVVALSQYCVELWNTDSRSKVADCRGHLSWVHGVMFSPDGSSFLTSSDDQTIRLWETKKVCKNSAVMLKQEVDVVFQENEVMVLAVDHIRRLQLINGRTGQIDYLTEAQVSCCCLSPHLQYIAFGDENGAIEILELVNNRIFQSRFQHKKTVWHIQFTADEKTLISSSDDAEIQVWNWQLDKCIFLRGHQETVKDFRLLKNSRLLSWSFDGTVKVWNIITGNKEKDFVCHQGTVLSCDISHDATKFSSTSADKTAKIWSFDLLLPLHELRGHNGCVRCSAFSVDSTLLATGDDNGEIRIWNVSNGELLHLCAPLSEEGAATHGGWVTDLCFSPDGKMLISAGGYIKWWNVVTGESSQTFYTNGTNLKKIHVSPDFKTYVTVDNLGILYILQTLE
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O14727 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Y24 | Phosphorylation | Uniprot | |
S31 | Phosphorylation | Uniprot | |
T48 | Phosphorylation | Uniprot | |
K63 | Ubiquitination | Uniprot | |
K131 | Ubiquitination | Uniprot | |
K139 | Ubiquitination | Uniprot | |
K144 | Ubiquitination | Uniprot | |
S161 | Phosphorylation | Uniprot | |
K189 | Ubiquitination | Uniprot | |
K192 | Ubiquitination | Uniprot | |
K198 | Ubiquitination | Uniprot | |
T204 | Phosphorylation | Uniprot | |
K224 | Ubiquitination | Uniprot | |
S238 | Phosphorylation | Uniprot | |
S248 | Phosphorylation | Uniprot | |
K267 | Ubiquitination | Uniprot | |
S268 | Phosphorylation | Q15418 (RPS6KA1) | Uniprot |
S272 | Phosphorylation | Uniprot | |
K277 | Ubiquitination | Uniprot | |
Y278 | Phosphorylation | Uniprot | |
K288 | Ubiquitination | Uniprot | |
K303 | Ubiquitination | Uniprot | |
S320 | Phosphorylation | Uniprot | |
K348 | Ubiquitination | Uniprot | |
S357 | Phosphorylation | Q15418 (RPS6KA1) | Uniprot |
S369 | Phosphorylation | Uniprot | |
S371 | Phosphorylation | Uniprot | |
K380 | Ubiquitination | Uniprot | |
Y382 | Phosphorylation | Uniprot | |
Y383 | Phosphorylation | Uniprot | |
K391 | Ubiquitination | Uniprot | |
K458 | Ubiquitination | Uniprot | |
S506 | Phosphorylation | Uniprot | |
K581 | Ubiquitination | Uniprot | |
K600 | Ubiquitination | Uniprot | |
K601 | Ubiquitination | Uniprot | |
K637 | Ubiquitination | Uniprot | |
K643 | Acetylation | Uniprot | |
K643 | Ubiquitination | Uniprot | |
K649 | Ubiquitination | Uniprot | |
K654 | Acetylation | Uniprot | |
K733 | Ubiquitination | Uniprot | |
K756 | Ubiquitination | Uniprot | |
K768 | Ubiquitination | Uniprot | |
K818 | Ubiquitination | Uniprot | |
S901 | Phosphorylation | Uniprot | |
T905 | Phosphorylation | Uniprot | |
K916 | Ubiquitination | Uniprot | |
K1048 | Ubiquitination | Uniprot | |
K1077 | Ubiquitination | Uniprot | |
K1079 | Ubiquitination | Uniprot | |
K1099 | Ubiquitination | Uniprot | |
T1103 | Phosphorylation | Uniprot | |
K1107 | Ubiquitination | Uniprot | |
T1108 | Phosphorylation | Uniprot | |
K1222 | Ubiquitination | Uniprot |
研究背景
Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. Isoform 6 is less effective in inducing apoptosis.
Cytoplasm.
Ubiquitous. Highest levels of expression in adult spleen and peripheral blood leukocytes, and in fetal brain, kidney and lung. Isoform 1 is expressed in heart, kidney and liver.
Monomer. Oligomerizes to a heptameric ring, known as the apoptosome, upon binding of cytochrome c and dATP. Oligomeric Apaf-1 and pro-caspase-9 bind to each other via their respective NH2-terminal CARD domains and consecutively mature caspase-9 is released from the complex. Pro-caspase-3 is recruited into the Apaf-1-pro-caspase-9 complex via interaction with pro-caspase-9. Interacts with APIP. Interacts (via CARD and NACHT domains) with NAIP/BIRC1 (via NACHT domain). Interacts with CIAO2A.
The CARD domain mediates interaction with APIP.
The monomeric form is autoinhibited in a closed conformation through a bound ADP at the nucleotide binding site. Exchange of ADP for ATP and binding of cytochrome c trigger a large conformational change where the first WD repeat region swings out, allowing the NB-ARC domain to rotate and expose the contact areas for oligomerization (By similarity).
研究領域
· Cellular Processes > Cell growth and death > p53 signaling pathway. (View pathway)
· Cellular Processes > Cell growth and death > Apoptosis. (View pathway)
· Cellular Processes > Cell growth and death > Apoptosis - multiple species. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > Platinum drug resistance.
· Human Diseases > Neurodegenerative diseases > Alzheimer's disease.
· Human Diseases > Neurodegenerative diseases > Parkinson's disease.
· Human Diseases > Neurodegenerative diseases > Amyotrophic lateral sclerosis (ALS).
· Human Diseases > Neurodegenerative diseases > Huntington's disease.
· Human Diseases > Infectious diseases: Bacterial > Legionellosis.
· Human Diseases > Infectious diseases: Bacterial > Tuberculosis.
· Human Diseases > Infectious diseases: Viral > Hepatitis B.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Small cell lung cancer. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.